Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chiglitazar vs Metformin in Non-obese PCOS
NCT06125587Phase 3Completed
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Nov 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chiglitazar in polycystic ovary syndrome (PCOS), sponsored by Shengjing Hospital of China Medical University. Started Nov 2023; status: completed.
02
Drugs
chiglitazar
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06125587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06125587.